October 5, 2022 Dr. Frank Mathias in an interview with the German edition "Biotechnology 2022" of GoingPublic
In an interview with Going Public, our CEO, Dr. Frank Mathias, shares his thoughts on what makes Germany stand out as a manufacturing hub, where opportunities and potential for improvements lie, and where politics could have an essential influence on the future development of the industry, as well as where and how the industry itself can prove its resilience.
Click here for the complete interview (in German): https://www.goingpublic.de/wp-content/uploads/epaper/epaper-Life-Sciences-3-2022/#12
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication